SEC Form 4 · accession 0001209191-18-041385
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Hoffman
Officer — CFO & SVP, Finance
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 9:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2018 | J | 744 | $13.2175 | A | 1,280 | D | |
| Common Stock | Jul 2, 2018 | M | 30,000 | $15.30 | A | 31,280 | D | |
| Common StockF3 | Jul 2, 2018 | S | 28,940 | $38.1516 | D | 2,340 | D | |
| Common StockF4 | Jul 2, 2018 | S | 1,060 | $38.7953 | D | 1,280 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $15.30 | Jul 2, 2018 | M | 30,000 | D | — | Apr 24, 2027 | Common Stock | 30,000 | 100,000 | D |
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2018.
- F2The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018.
- F3The range of sales prices received was $37.60 to $38.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- F4The range of sales prices received was $38.625 to $38.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- F5Options vest and become exercisable with respect to 32,500 shares on the first anniversary of his first day of employment (the "Grant Date"), followed by 97,500 shares vesting ratably each month over the subsequent three years, such that 130,000 options will be fully vested on the four year anniversary of the Grant Date.